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ABSTRACT 
 
Objective 
 
The efficacy of spoken language comprehension therapies for persons with aphasia 
remains equivocal. We investigated the efficacy of a self-led therapy app, ‘Listen-In’, and 
examined the relation between brain structure and therapy response.  
 
Methods 
 
A cross-over randomised repeated measures trial with five testing time points (12-
week intervals), conducted at the university or participant’s homes, captured baseline (T1), 
therapy (T2-T4), and maintenance (T5) effects. Participants with chronic post-stroke aphasia 
and spoken language comprehension impairments completed consecutive Listen-In and 
standard care blocks (both 12-weeks with order randomised). Repeated measures ANOVAs 
compared change in spoken language comprehension on two co-primary outcomes over 
therapy versus standard care. Three structural MRI scans (T2-T4) for each participant 
(subgroup, n=25) were analysed using cross-sectional and longitudinal voxel-based 
morphometry. 
 
Results 
 
Thirty-five participants completed, on average, 85 hours (IQR=70-100) of Listen-In 
(therapy first, n=18). The first study-specific co-primary outcome (Auditory Comprehension 
Test, ACT) showed large and significant improvements for trained spoken words over 
therapy versus standard care (11%, Cohen’s d=1.12). Gains were largely maintained at 12 
and 24 weeks. There were no therapy effects on the second standardised co-primary outcome 
(Comprehensive Aphasia Test: Spoken Words and Sentences). Change on ACT trained 
words was associated with: volume of pre-therapy right hemisphere white matter; and post-
therapy grey matter tissue density changes in the right temporal lobe.  
 
Conclusions 
 
Individuals with chronic aphasia can improve spoken word comprehension many 
years after stroke. Results contribute to hemispheric debates implicating the right hemisphere 
in therapy-driven language recovery. Listen-In will soon be available on GooglePlay. 
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INTRODUCTION 
Auditory spoken language comprehension impairments are common in individuals 
with aphasia [1], and for many, these remain chronic. Those with severe spoken language 
comprehension impairments have worse outcomes and higher drop-out rates from 
rehabilitation programs [2]. Developing effective evidence-based therapies for such 
impairments is a priority.  
A recent Cochrane review, and two further randomised controlled trials (RCTs), have 
provided unequivocal evidence that speech and language therapy (SLT) benefits people with 
aphasia across multiple language domains [3–5]. However, surprisingly few investigations 
have focused on spoken language comprehension therapies. Several single cases and small 
group studies have investigated several different approaches (e.g., phonological 
discrimination training [6,7], semantic-based therapies [8], or a mixture of both [9]) with 
inconclusive results. These equivocal findings are unsurprising given the overall small 
numbers of participants and variability of therapy tasks employed.  
The majority of these studies delivered small doses of therapy (under 20 hours in 
total). However, reviews of speech and language intervention studies for PWA have revealed 
that high dose therapies are associated with superior outcomes (~100 hours) [5,10]. These 
single case and small group interventions have typically targeted a specific aspect of auditory 
comprehension (e.g., phonological discrimination). As spoken language comprehension 
necessitates effective integration of acoustic, phonological, and semantic processing, 
therapies that only target specific aspects may fail to adequately capture the interactive nature 
of the system.  RCTs of high dose spoken language comprehension therapy are needed, and 
the absence of such trials motivated this study.  
In Phase 1 we collaborated with persons with aphasia (PWA) and game developers to 
create a novel gamified therapy application (‘Listen-In’) that would support self-led high 
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dose therapy by PWA (submitted elsewhere). The therapeutic component of Listen-In 
involved massed practice of spoken word-to-picture matching (SWPM) challenges that 
captured the spoken language comprehension system more broadly by incorporating 
phonological processing (e.g., minimal pair foils) and semantic processing (e.g., semantic 
foils) as well as the processing of spoken words within more naturalistic auditory scenes (i.e., 
within phrases and sentences, and within background noise). Here, we present the results of 
the Phase 2 RCT of Listen-In. We hypothesised that Listen-In would improve spoken word 
comprehension for trained items in persons with chronic post-stroke aphasia, and that 
generalisation might occur for untrained items through improvements in phonological 
processing.  
Previously, patterns of left-hemisphere brain damage have been associated with 
lexical-based therapy outcomes in individuals with chronic aphasia [11]; however, there have 
been no equivalent studies for spoken word comprehension. Given that specific predictions 
are clearly premature and that some models of speech processing posit a role for the right 
hemisphere [12],  we used a whole-brain analysis with structural MRI (sMRI) to investigate 
whether the volume of pre-therapy grey and white matter was associated with any therapy 
effects.  
We also wanted to investigate whether Listen-In therapy induced changes in brain 
structure, given that experience-dependent changes in grey and white matter structure have 
been reported in response to these types of repetitive training tasks in healthy individuals 
[13]. Whilst there have been no longitudinal structural imaging studies of spoken language 
comprehension therapy, two functional imaging studies of auditory therapy in PWA 
identified functional changes in the auditory cortex, part of the superior temporal gyrus 
[7,14].  Functional imaging studies in healthy individuals have identified an antero-lateral 
gradient of speech processing, away from the auditory cortex along the superior temporal 
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gyrus (STG) [15]. Given that Listen-In engages the speech perception system, we expected 
that if brain changes were observed they may be located in the region of the STG. In this 
analysis, we present a novel application of longitudinal sMRI.  
 
MATERIALS AND METHODS 
 
Study design 
We used a cross-over randomised repeated measures design, with five evenly-spaced 
testing time points (T1-T5) at 12-week intervals (Fig. 1). Ethical approval was obtained from 
the National Research Ethics Service, Hampstead Committee (15/LO/0569), and the trial 
protocol was pre-registered on ClinicalTrials.gov (NCT02540889).  
[Figure 1 – study design] 
 
Participants 
Participants were recruited between 22 March 2016 and 7 April 2017 from the 
Predicting Language Outcome and Recovery After Stroke (PLORAS) database [16]; a local 
outpatient aphasia clinic; and focus groups in Phase 1. Inclusion criteria at the screening 
assessment were: (i) more than six months post-stroke; (ii) English as a dominant language; 
(iii) scores below 26/30 for comprehension of Spoken Words and 28/32 for Spoken 
Sentences on the Comprehensive Aphasia Test (CAT) [17]. Exclusion criteria were: (i) a 
premorbid significant neurological (e.g., degenerative brain disease) or psychiatric (e.g., 
major depression) disorder (self-report at screen); (ii) unable to give informed consent. 
Thirty-eight individuals were enrolled over the course of the study; data are presented for 35 
participants who completed both cross-over study blocks (Fig. 2). All participants gave 
written informed consent before commencing the study. Participants had a mean age of 61 
years (SD=12 years), and mean time since stroke of 76 months (SD=59) (Supplementary 
Table 3).  
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[Figure 2 – CONSORT flow diagram) 
 
Randomisation and blinding 
A researcher blinded to participants’ identities and not involved in enrolment or 
testing used a randomisation minimisation procedure [18] to allocate participants to therapy 
first (Group 1, n=18) or standard care (Group 2, n=17) to minimise potential differences 
between groups. This method considered severity of spoken language comprehension 
impairment (Comprehensive Aphasia Test, Spoken Word and Sentence subtests [17]) and 
time since stroke with equal weighting.  
 
Intervention and standard care blocks 
The intervention block consisted of 12 weeks of daily self-managed spoken word 
comprehension therapy (Listen-In) on a computer tablet with a target dose of 100 hours (~80 
minutes per day). The standard care block consisted of participants’ usual daily activities. 
The app was developed for the trial, in collaboration with software developers (SoftV) and 
PWA [19]. Listen-In therapy consisted of spoken word/phrase/sentence-to-picture matching 
challenges that users progressed through based on an adaptive algorithm (see Supplementary 
Material). In each challenge, the participant heard a word presented on its own, or within a 
phrase or sentence (e.g. ‘clock’, ‘an old clock, ‘the man holds a clock’) (Supplementary 
Tables 1 and 2). The target picture (e.g., ‘clock’) was always flanked by two to five foils, that 
were a combination of semantic (e.g., ‘stopwatch’), phonological (e.g., ‘lock’ and ‘rock’), 
and unrelated (e.g., ‘shoe’) foils (Supplementary Fig. 1). Time participants spent on therapy 
challenges (in seconds) was recorded by the app daily; automated shut-down after 3 minutes 
of inactivity ensured high fidelity data on dose.  
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Outcomes 
The first co-primary outcome assessed spoken language comprehension on two 
standardised subtests of the CAT [17], Spoken Words and Spoken Sentences. Each subtest 
contained 15 and 16 spoken word and sentence-to-picture matching trials respectively, where 
the target was always flanked by three foils. Maximum scores were 30 for Spoken Words and 
32 for Spoken Sentences, with each trial scored as follows: correct=2 points; correct but 
repeated or delayed (>5 seconds)=1 point; incorrect=0 points. Raw scores were converted to 
a percentage for statistical analyses, and are presented as raw scores in Supplementary Table 
4. 
A second study specific co-primary assessment was created (prior to the trial 
commencing) to measure comprehension of trained and untrained spoken words (see 
Supplementary Material). The Auditory Comprehension Test (ACT) contained 220 spoken 
word/phrase/sentence-to-picture matching trials (‘items’), that always contained one target 
picture, and five foils (phonological, semantic, and unrelated) (Supplementary Fig. 2). The 
ACT consisted of two sets of psycholinguistically matched items (Set A/Set B) that formed 
participants’ trained (n=110) and untrained (n=110) items (Supplementary Fig. 3). To reduce 
possible stimulus-response binding effects (identity priming), all images used in the ACT 
were different from those used in Listen-In therapy. Verbal stimuli in the ACT and Listen-In 
were also randomly selected on each trial from a small pool of male and female versions of 
the audio recording. Participants scored 1 point for a correct response, and this was converted 
to percentage correct for trained (n=110) and untrained (n=110) items. 
Three secondary outcomes measured change in other auditory tasks (phoneme 
discrimination, environmental sound discrimination, spoken vocabulary comprehension) to 
assess the specificity of any therapy effects (see Supplementary Material).  
 Primary and secondary outcomes were collected at every time point (T1-T5) by three 
speech and language therapists and one research assistant. Testing sessions were conducted at 
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the Institute of Cognitive Neuroscience (UCL) or in participants’ homes and were carried out 
over sessions of 1-2 days within the same week.  
 
Baseline data  
Baseline data are presented in Supplementary Table 3. All participants met diagnostic 
criteria for aphasia in accordance with the CAT for both receptive and expressive subtests. 
By definition, all participants performed below aphasia cut-off criterion on Spoken Word and 
Sentence comprehension subtests at a screen prior to T1. Hearing levels were tested using 
pure-tone free field audiometry at 1000, 2000, and 4000 Hz, and participants were 
encouraged to wear hearing aids if prescribed.  
 
MRI data acquisition and lesion identification 
Structural MRI scans were obtained for all participants who met safety requirements 
for scanning (n=25) and were acquired at T2, T3, and T4 on the day of testing or within a 
week if there were scheduling constraints (mean days between scans: T2-T3=85, SD=4; T3-
T4=86 SD=6). T1-weighted images were acquired on a Siemens 1.5T Avanto (n=7) or 
Siemens 3T Trio (n=18) scanner with standard 20 channel head coils using standard 
acquisition sequences with a voxel resolution of 1mm
3
 (see Supplementary Material).  
Figure 3 displays the distribution of lesions across 25 participants. All had extensive 
damage throughout the left perisylvian middle cerebral artery territory. Three participants had 
additional right hemisphere (non-aphasic) lesions (prior to their left hemisphere infarct) and 
one of these participants also had a lesion in the left cerebellum.  
[Figure 3 – Lesion overlap map] 
 
Statistical analysis 
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We conducted an a-priori power calculation, which indicated that 32 participants 
would enable us to detect a small effect size (Cohen’s dz=0.45) with 80% power using a 
paired samples t-test (one way alpha 0.05). We anticipated a dropout rate of 20%, and 
therefore aimed to recruit 38 participants (see Supplementary Material). 
 
Behavioural outcomes  
 
To test the efficacy of Listen-In, and in-line with the crossover study design, we 
compared change over therapy and standard care for all primary and secondary outcomes. 
Change was calculated as raw percentage change over study blocks (i.e., Group 1 therapy 
[Δ(T3-T2)], standard care [Δ(T4-T3)]; Group 2 therapy [Δ(T4-T3)]; standard care [Δ(T3-T2)]). 
For the ACT, we used repeated-measures ANOVA with two within-subject factors: change 
(Δ therapy, Δ standard care) and item condition (trained/untrained). For all other outcomes, 
one-way repeated measures ANOVAs were conducted. All ANOVAs included Group as a 
between-subjects factor. Planned post-hoc paired samples t-tests (two-tailed) explored 
significant interactions and assessed change over baseline and maintenance. The alpha-level 
for all analyses was p < 0.05.  
 
Cross-sectional voxel-based morphometry 
 
To investigate whether the pre-therapy brain structure was associated with response to 
therapy, we used whole-brain voxel-based morphometry (VBM) (see Supplementary 
Material) [20]. This produced two tissue images (grey and white matter) for each participant 
at baseline (n=25) that were entered into two multiple linear regression models to identify 
regions where pre-therapy volume correlated with significant behavioural therapy effects. 
Effects of age, time since stroke, and lesion volume were included as covariates of no 
interest. The statistical voxel-level threshold was set at a standard level of p <0.001 with 
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voxel and cluster-level significance set at p<0.05 after family-wise error (FWE) correction 
for multiple comparisons across the whole search volume.  
 
Longitudinal voxel-based morphometry 
 
To investigate possible changes in brain structure associated with therapy, we 
explored whether behavioural therapy effects covaried with any changes in tissue density. 
First, we quantified change in tissue density (using unprocessed whole-brain scans) over 
therapy (Group 1 [Δ(T3-T2)]; Group 2 [Δ(T4-T3)]) and standard care blocks (Group 1 [Δ(T4-
T3)]; Group 2 [Δ(T3-T2)]) for each participant. To carry out the aforementioned process, we 
used serial longitudinal registration in SPM12 [21] (for methodology see Supplementary 
Material). Resultant probabilistic change images were subtracted within-subject (therapy 
minus standard care) to produce one final image for each participant that represented a 
change in voxel density over the therapy block, over and above the period of standard care. 
Finally, images were normalised to MNI space and smoothed with an isotropic kernel of 
6mm FWHM. 
These images were entered into simple linear regression models in SPM12 to identify 
any regions where a change in tissue density correlated with significant behavioural therapy 
effects. No other regressors were modelled as participants acted as their own control. Our 
statistical voxel-level threshold was p <0.001 with voxel and cluster-level significance set at 
p <  0.05 after FWE correction for multiple comparisons across the whole brain, and within a 
bilateral STG mask (WFU PickAtlas toolbox, voxels=10496).  
 
RESULTS 
There were no significant differences between Group 1 and Group 2 for age, time 
since stroke, or CAT Spoken Words and Spoken Sentences at baseline (T1), in line with the 
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minimisation randomisation method (all p≥0.20). On the ACT,  Group 1 scored significantly 
better than Group 2 at baseline (t(33)=2.52, p=.02). Between T1 and T2 (baseline change) 
performance on CAT Spoken Words and Sentences remained stable across the whole group 
(both t≤1.75, p≥0.09). For the ACT, there was a small significant improvement between T1 
and T2 (M=2%, SD=6%, t(34)=2.37, p=0.02) (for reliability analysis see Supplementary Fig. 
4).  
Listen-In dose 
Participants spent an average of 85 hours (interquartile range (IQR)=70-100) on 
Listen-In therapy over 12-weeks, completed ~27,000 individual challenges each 
(IQR=21,000-33,000), and of these 18% (IQR=14-21%) targeted words probed within the 
ACT (trained items). For each trained word, participants completed an average of 43 
(IQR=35-52) challenges. 
 
Behavioural therapy effects  
Post-hoc analyses indicated this study was sensitive to small therapy effects (Cohen’s 
α=0.05; 1-β=0.80, dz=0.49, see Supplementary Material). Results for all outcomes are 
presented in Supplementary Table 4.  
There was no significant difference in performance change between therapy (Group 1 
[Δ(T3-T2)]; Group 2 [Δ(T4-T3)]) and standard care (Group 1 [Δ(T4-T3)]; Group 2 [Δ(T3-T2)]) 
for CAT Spoken Words (F(1, 33)=1.87, p=0.18, η
2
=0.05) and Spoken Sentences (F(1, 
33)=0.52, p=0.48, η
2
=0.02). For the ACT, there was a significant interaction between block 
(Δ therapy, Δ standard care) and item condition (trained items, untrained items) (F(1, 
33)=39.16, p<0.001, η
2
p=0.54) (Fig. 4). This was driven by improvements for trained items 
(Fig. 4A) over therapy versus standard care (t(34)=4.09, p<0.001, Cohen’s dz=1.32). For 
trained items, from pre to post therapy, effect sizes were large for both unstandardised and 
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standardised measures: 11% (absolute change), 30% (%back2normal); and Cohen’s d=1.12 
(see Supplementary Material). Figure 4B shows the variability in magnitude of therapy 
effects across participants. There was a small but non-significant loss of therapy effects for 
Group 1 at 12 weeks (T4-T3, t(17)=-2.01, p=0.06). For the remaining maintenance periods 
(Group 1 T5-T4; Group 2 T5-T4, n=15) there were no significant declines in performance 
(both p≥0.70). All secondary outcomes showed no significant changes in performance over 
therapy versus standard care (one way ANOVAs all p≥0.11). 
 [Figure 4 – Behavioural therapy effects] 
Pre-therapy brain structure and response to therapy 
Two multiple linear regression models were conducted separately for grey and white 
matter with change on trained items as the behavioural variable (Group 1 [Δ(T3-T2)]; Group 2 
[Δ(T4-T3)]) and age, time since stroke, and lesion volume as covariates of no interest (Fig. 
5A).  Figure 5B displays significant clusters of voxels where greater volume at baseline 
covaried with greater response to therapy. In grey matter, one significant cluster was 
identified in the right head of the caudate nucleus (Cluster 1). In white matter, four significant 
clusters were identified. In the right hemisphere, these were Cluster 3 (white matter intrinsic 
to the temporal lobe) and Cluster 4 (white matter extending from the fusiform cortex to 
subcortical structures). In bilateral hemispheres, these were Cluster 2 (right ventrolateral 
prefrontal cortex) and Cluster 5 (subcortical white matter, mainly in the left body of the 
cerebellum). 
 
Region Side 
Coordinates 
(mm) Cluster 
size, kE 
T 
x y z 
Cross-sectional VBM 
Grey matter:     
Right head of caudate nucleus R 12 12 0 435 4.94 
White matter:     
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Temporal lobe R 64 -12 -26 1589 4.11 
Ventrolateral prefrontal cortex B 44 32 6 2415 5.39 
Deep white matter (fusiform cortex to thalamus) R 30 -38 -8 2050 4.90 
Bilateral cerebellum B -6 -62 -28 822 5.54 
Longitudinal VBM 
Grey matter:     
Right posterior superior temporal gyrus R 66 -40 12 154 5.05 
White matter:     
Left middle superior temporal gyrus L -56 -22 -4 106 4.59 
Table 1. Brain regions associated with response to Listen-In therapy. Coordinates are in MNI space and 
represent the peak voxel in that cluster. FWE=family wise error. Voxel wise threshold set at p<0.001, p<0.05 
FWE correction following small volume correction with a bilateral superior temporal gyrus mask 
(voxels=10496). B=bilateral; L=left;  R=right; kE=cluster size (voxels); T=t-value.  
 
[Figure 5 – Cross-sectional VBM results] 
Change in brain structure induced by therapy  
No clusters or peaks survived family-wise error correction (p<0.05) across the whole 
brain. Figure 6 shows significant cluster level results from white (Fig. 6A) and grey (Fig. 6B) 
matter VBM analyses, following small volume correction with a bilateral STG mask and 
correction for multiple comparisons (Table 1). Two clusters were identified: grey matter in 
the right posterior STG, and white matter in the left middle STG bordering the superior 
temporal sulcus. The scatterplots show individual participant results for change in 
performance on trained items by the change in relative tissue density. (For overall density 
change over time (T1-T4) see Supplementary Fig. 5).  
[Figure 6 – Longitudinal VBM results] 
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DISCUSSION 
 
Behavioural therapy effects 
We present the first cross-over RCT of spoken language comprehension therapy, 
using a novel tablet-based therapy app, Listen-In. We observed large, item-specific 
improvements in spoken word comprehension when comparing the therapy block with an 
equivalent period of no therapy. Participants achieved a large average dose of therapy, much 
larger than previous speech comprehension studies [6–9], and much closer to the large doses 
observed in positive intervention studies [10]. The effect size compares favourably with other 
lexical based interventions in reading [22] and naming [23]. Importantly, considering the 
amount of time and effort participants contributed, improvements for trained items were 
maintained up to 24 weeks after the therapy blocks were completed. Participants varied in the 
severity of their spoken language comprehension impairments, suggesting Listen-In therapy 
is suitable for a range of PWA.  
Improvements did not generalise to untrained items, consistent with item-specific 
effects frequently observed in lexical based therapies [24]. However, while effects were item 
specific, they were not exemplar specific, as images and verbal stimuli varied between 
therapy and the assessment task (ACT), such that participants were able to generalise their 
improvements to novel exemplars of that word. This RCT demonstrates that item-specificity 
should be expected for some interventions, and necessitates that clinicians tailor ‘to be 
trained’ items to each individual. 
 
Role of pre-therapy brain structure 
We investigated whether variation in response to therapy could be partly accounted 
for by differences in pre-therapy brain structure. With the exception of one cluster (head of 
the caudate), the significant clusters were located in white matter underlying frontal and 
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temporal cortices, as well as subcortical structures, suggesting that greater integrity of white 
matter networks facilitated participants’ response to therapy.  
It is not possible to distinguish whether variability in volume is due to normal pre-
morbid individual differences in white matter volume, neurobiological sequelae of stroke, or, 
most likely, a mixture of both. Pre-morbid possibilities include differences in cognitively 
active lifestyles,  white matter asymmetries [25], and declines in volume due to normal 
ageing [26]; post-stroke possibilities include accelerated stroke-related atrophy [27] and 
Wallerian (dying back or retrograde degeneration of white matter connections) and 
transcallosal (trans-synaptic, anterograde degeneration of white matter connections ) 
degeneration. It is also possible that post-stroke reorganisation may play some role, as 
increased right hemisphere grey matter volume has been reported in chronic aphasic 
participants [28]. Regardless of the underlying cause of variability, these findings 
demonstrate a link between the neuroanatomical regions identified in our data and therapy-
related language recovery.  
The role of the right hemisphere in language recovery is a topic of much debate [29]. 
A common finding is increased right hemisphere activity in regions homologous to the 
lesioned left hemisphere [30]. However, the nature of this activity is widely debated. Three 
prominent accounts are adaptive compensation [31], upregulation of domain-general neural 
networks rather than language-specific reorganisation [32], and maladaptive interference due 
to release of transcallosal disinhibition [33]. The majority of significant clusters in our data 
were located in the right hemisphere, in frontal and temporal regions homotopic to key left 
hemisphere language nodes. Given that participants with greater volume in these regions 
made greater gains in spoken word comprehension, our interpretation is that greater volume 
reflects a better functioning system in accordance with a facilitatory account of right 
hemisphere involvement (e.g., upregulation of support mechanisms, or reorganisation).  
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 We also identified subcortical structures known to support and monitor language-
specific cortical activity. These include the head of the caudate nucleus, a region with 
extensive cortical connectivity [34] and implicated in cognitive control of language in the 
dominant hemisphere [35]; deep white matter which may relate to language monitoring 
functions that have been ascribed to some of the basal ganglia-thalamocortical circuits [36]; 
and the cerebellum, which is involved in a range of motor, cognitive and language tasks [37].  
 
Therapy related changes in tissue density  
We identified two clusters where change in tissue density covaried with a change in 
trained item performance. In the left hemisphere, we identified a white matter cluster 
underlying the middle STG. As the scatterplot illustrates (Fig. 6C), many participants show a 
lesion at this location, and the remaining correlation is being driven by two outlying 
participants who show striking declines in density relative to the group. For these reasons, 
any interpretation is highly speculative. However, this cluster is located in close proximity to 
part of the cortex implicated in phonetic speech processing and learning new words in 
healthy individuals [15,38,39], a plausible region to predict neuroplasticity given the 
demands of Listen-In.  
In the right hemisphere, we observed a grey matter cluster in the posterior STG 
(Wernicke’s area homologue), a region proposed to be part of bilateral and parallel early 
speech processing streams [12,38]. When the data from this region was plotted (Fig. 6D), two 
types of participants were identified: those with a relative increase in tissue density during 
therapy and who responded well (upper right quadrant); and those with a relative decrease in 
tissue density and who responded poorly (lower quadrants). The relative changes in tissue 
density within the right hemisphere are of a small magnitude and are on a background of the 
global, and somewhat accelerated, atrophy seen in individuals with stroke (~1% per year) 
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[27]. Given this background of likely atrophy over time, maintenance of tissue density, or 
lesser decline, may well be regarded as a demonstration of experience-dependent plasticity in 
this particular population [40]. Further studies are needed to specifically address this 
mechanism. Nevertheless, we have demonstrated more broadly, for the first time, a 
relationship between the structural integrity of this right hemisphere region and therapy-
induced improvements in understanding spoken language after stroke. 
 
Limitations and future directions 
Whilst some may consider lack of generalisation (to untrained words) to diminish the 
clinical utility of Listen-In, it is important to note that participants showed generalisation 
across different exemplars of trained items, and improvements were maintained as long as 24 
weeks later. As relatively little research has been reported for spoken language 
comprehension therapies, improvements, whether item specific or otherwise, are an important 
step forward for aphasia rehabilitation. Future work is now required to investigate possible 
mechanisms of generalisation, to maximise benefits for PWA . We have a manuscript in 
preparation that will investigate one aspect of this.  
It is also unclear how task-based item-specific improvements may relate to improved 
spoken word comprehension in everyday environments. This is a methodological challenge 
given the often hidden nature of comprehension. Future research may investigate how 
improvements generalise across tasks and settings.  
We aimed to investigate the efficacy of high dose (hours) therapy, as well as its’ 
feasibility. One limitation is that early phase dosing investigations were not conducted prior 
to the start of the trial. These may have helped to identify a different, perhaps more suitable, 
target dose. Listen-In would benefit from employing a systematic therapy development 
pipeline to specify the suitable parameters for delivery.  
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This efficacy study showed improvements in the context of a well-controlled RCT 
with a highly specific population. The effectiveness of Listen-In now needs to be evaluated in 
the real world setting, and a pragmatic trial will be soon be underway. 
 
CONCLUSION  
We report the first RCT of high-dose spoken language comprehension therapy in 
individuals with chronic aphasia using a novel, self-led tablet-based spoken word 
comprehension therapy ‘Listen-In’. These results demonstrate that individuals with chronic 
aphasia can significantly improve their comprehension of spoken words many years after 
stroke, given a sufficient dose. Future work is needed to investigate optimal dose, intensity, 
and distribution, as well as generalisation of improvements to communication environments. 
Structural imaging results add to the topical debate of hemispheric contributions to language 
recovery, by providing novel indirect evidence that right-hemisphere regions support the 
recovery of language in PWA. Researchers, clinicians, and individuals with aphasia can 
access the public release of Listen-In soon, with a free trial period: 
www.ucl.ac.uk/ion/Listen-In. 
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FIGURE LEGENDS 
Figure 1. Group randomised cross-over study design.  
 
Figure 2. Consolidated Standards of Reporting Trials (CONSORT) flow diagram.  
 
Figure 3. Lesion overlap map for 25 participants in MNI space. Numbers represent MNI 
coordinates of brain slices along the x-axis. The colour bar represents the number of 
participants with a lesion at that location, from 1 to 25.  
 
Figure 4. Therapy effects on spoken word comprehension ability. (A) Performance on the 
ACT, for trained and untrained items, by group. G1=Group 1; G2=Group 2. Error bars are 
within-subject standard error of the mean (for G2, two participants data were excluded from 
all standard error calculations due to no T5 data). (B) Pre and post-therapy performance on 
ACT trained items, for all participants (n=35).  
 
Figure 5. Pre-therapy brain regions associated with therapy effects (VBM). (A) Multiple 
linear regression design matrix in SPM12; (B) Average grey matter slices from 25 
participants, showing grey (blue) and white (yellow) matter clusters where volume at 
baseline positively covaried with change on trained items (%) from pre- to post-therapy. 
Voxel-wise threshold set at p<0.001. All clusters survived FWE correction at p<0.05. 
Numbered regions are as follows: (1) right caudate nucleus; (2) right ventrolateral 
prefrontal cortex, genu of the corpus callosum, anterior corona radiata; left: paracingulate 
cortex; (3) temporal lobe; (4) cluster extending from the right fusiform cortex to thalamus; 
(5) bilateral cerebellum.   
 
Figure 6. Changes in brain structure associated with therapy effects (VBM). Average grey 
matter slices from 25 participants showing regions of (A) white and (B) grey matter where a 
change in tissue probability over therapy significantly covaried with change on trained items 
(%) from pre- to post-therapy. Voxel-wise threshold set at p<0.001, with FWE correction at 
p<0.05, following small volume correction with a bilateral superior temporal gyrus mask. 
Below, scatterplots show percentage change on trained items from pre- to post-therapy 
plotted against change in tissue density for (C) white and (D) grey matter clusters. Tissue 
density values taken as an average of a 5mm sphere around the peak voxel in each cluster. 
Unfilled circles are participants with a lesion at the peak voxel in that cluster. Note: on the y-
axis, a negative value reflects a relative decrease in density, while a positive value reflects a 
relative increase (where relative change is within-subject change in tissue density over 
therapy more than standard care).  
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